SCHEMBL6985609

SCHEMBL6985609

CCOC(=O)CN(CC(c1ccccc1)c1ccccc1)c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.39
NR3C1 P04150 1/20 0.39
EP300 Q09472 2/20 0.38
PARP1 P09874 1/20 0.38
MAPT P10636 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK3 Q15120 1/20 0.37
PDK4 Q16654 1/20 0.37
TP53 P04637 2/20 0.37
CCR5 P51681 1/20 0.37
TSHR P16473 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6982684 0.90 KDM1A (0.43) NOTUMNR3C1PARP1MAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL6984309 0.88 F2 (0.43) NOTUMPDK1PDK2PDK3PDK4
SCHEMBL6985390 0.87 ALDH1A1 (0.40) NOTUMNR3C1PARP1MAPTSMN1; SMN2
SCHEMBL6985613 0.85 CCR5 (0.37) NOTUMEP300MAPTSMN1; SMN2NPC1
SCHEMBL7958945 0.85 PDK1 (0.41) NOTUMNR3C1PARP1MAPTSMN1; SMN2
SCHEMBL6984161 0.84 PARP1 (0.39) NOTUMNR3C1PARP1MAPTSMN1; SMN2
SCHEMBL6987763 0.84 NR3C1 (0.47) NR3C1MAPTMAPK1ALDH1A1USP2
SCHEMBL6980751 0.82 NOTUM (0.44) NOTUMNR3C1PARP1MAPTSMN1; SMN2
SCHEMBL6979149 0.81 PARP1 (0.40) NOTUMNR3C1PARP1MAPTSMN1; SMN2
SCHEMBL6979167 0.79 KDM1A (0.47) NR3C1PARP1MAPTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed